<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><label>Table 1.</label><caption><title>Summary of the study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Number of participating hospitals</th><th>3 (Serbia, Italy, Romania)</th></tr></thead><tbody><tr><td>Study duration</td><td>2 years (Jan 2011 - Dec 2012)</td></tr><tr><td>Inclusion criteria</td><td>Inpatients of medical and surgical wards, adults, non-pregnant, ESBL producting Enterobacteriaceae carriers (at admission)</td></tr><tr><td>Number of patients followed up</td><td>133 (including one with a single swab taken)</td></tr><tr><td>Intervals between rectal swabs</td><td>two to three days</td></tr><tr><td>qPCR targets</td><td>bla<sub>CTX-M</sub> (ESBL resistance gene), 16S rRNA (total bacterial load)</td></tr><tr><td>Number of different antibiotics used</td><td>35</td></tr></tbody></table><table-wrap-foot><fn><p>This study (registration number NCT01208519) was conducted by the SATURN consortium, supported by the European Commission under the 7th Framework Program.</p></fn></table-wrap-foot></table-wrap>